Björn Chapuy

24PUBLICATIONS
226CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Apr 23, 2026
Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis.

|Oct 22, 2025
Prognostic value of inflammation-based scores in patients with R/R LBCL treated with CD3×CD20 bispecific T-cell engagers.

Giulia Magno, Kai Rejeski, Giulia Rappa

|Oct 16, 2025
A CD22-specific T-cell receptor enables effective adoptive T-cell therapy for B-cell malignancies.

Simone Rhein, Neşe Çakmak-Görür, Corinna Grunert

|Aug 04, 2025
Discovery of molecularly-informed therapeutic strategies for mature T-cell leukemias and lymphomas.

Nicole Schmidt, Kevin Kornrumpf, Lena Ries

|Jul 12, 2025
Clinical Predictors and Recurrence Characteristics Following Radiotherapy for Primary Central Nervous System Lymphoma: A Retrospective Cohort Study.

Jan Carl Bigge, Stephanie Bendrich, Hannes Treiber

|Apr 16, 2025
Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma.

Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib

Pageof 4

Frequent Collaborators

5 joint publications

Ulrich Keller

5 joint publications

Kamil Bojarczuk

4 joint publications

Gero Knittel

4 joint publications

Bastian von Tresckow